The interaction of isavuconazole with immunosuppressors (tacrolimus, cyclosporin A, or
sirolimus) against 30 Aspergillus isolates belonging to the most common species …

In this study the activity of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin
against 224 clinical isolates of Aspergillus spp. originating from seven Italian hospitals, was …

Background The voriconazole and echinocandin combination has been found to be
synergistic in vitro and in vivo against most Aspergillus fumigatus isolates, both with a WT …

In vitro combinations of isavuconazole with echinocandins were evaluated against 30
Aspergillus strains with a two-dimensional checkerboard microdilution method and an agar …

The in vitro interactions of isavuconazole in combination with colistin were evaluated against
55 clinical Aspergillus species isolates belonging to the five most important species …

Azole resistance is an emerging problem in Aspergillus fumigatus which translates into
treatment failure. Alternative treatments with new azoles may improve therapeutic outcome …

Isavuconazole, the active moiety of the water-soluble prodrug isavuconazonium sulfate, is a
triazole antifungal agent for the treatment of invasive fungal infections. The purpose of this …

Triazoles are first-line agents for treating aspergillosis. The prevalence of azole resistance in
Aspergillus fumigatus is increasing, and cross-resistance is a growing concern. In this study …

Epidemiological cutoff values (ECVs) were established for the new triazole isavuconazole
and Aspergillus species wild-type (WT) MIC distributions (organisms in a species-drug …

Recently isavuconazole, an experimental triazole agent, was found to be active against
Aspergillus species. As Aspergillus flavus is the second‐most common Aspergillus species …